United Heart & Vascular Clinic - Nasseff Specialty Center (MHI East)
Welcome,         Profile    Billing    Logout  
 5 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bank, Alan J
METEOR-CRT, NCT04083690: Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients

Recruiting
N/A
120
US
Reprogramming of CRT Device Settings to Optimal Electrical Synchrony
Allina Health System
Heart Failure, Systolic
10/23
10/24
NCT04763460: Effects of CRT Optimization as Assessed by Cardiac MR

Recruiting
N/A
40
US
Programming of CRT device settings
Allina Health System, Minneapolis Heart Institute Foundation
Heart Failure, Systolic
04/24
04/25
SWAN, NCT04971993: Step and Walking Pattern From Cardiac Monitor Study

Terminated
N/A
40
US
Wearable Cardiac Monitor
Boston Scientific Corporation
Heart Failure NYHA Class II, Heart Failure NYHA Class III, Insertable Cardiac Monitor
10/23
10/23
Brown, Christopher
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting
3
9541
Europe, Canada, Japan, US, RoW
Obicetrapib, Placebo
NewAmsterdam Pharma, Monash University
Atherosclerotic Cardiovascular Disease
11/26
11/26
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Active, not recruiting
3
14013
Europe, Canada, US, RoW
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml
Novartis Pharmaceuticals
Primary Prevention of Atherosclerotic Cardiovascular Disease
04/29
04/29
NCT05173532: The Prescriptive Validity of a Novel Fall Risk Clinical Prediction Rule for People With COPD

Active, not recruiting
N/A
88
US
Balance Training, Breathing and Stretching Exercises
Texas Woman's University
Pulmonary Disease, Chronic Obstructive
12/22
12/22
METEOR-CRT, NCT04083690: Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients

Recruiting
N/A
120
US
Reprogramming of CRT Device Settings to Optimal Electrical Synchrony
Allina Health System
Heart Failure, Systolic
10/23
10/24
NCT04763460: Effects of CRT Optimization as Assessed by Cardiac MR

Recruiting
N/A
40
US
Programming of CRT device settings
Allina Health System, Minneapolis Heart Institute Foundation
Heart Failure, Systolic
04/24
04/25
NCT05966662: Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Active, not recruiting
N/A
145
US
IVL with Shockwave C2+ 2Hz Coronary IVL Catheter
Shockwave Medical, Inc.
Coronary Artery Disease, Myocardial Infarction
01/25
12/25
RESTORE, NCT04803214: ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation

Active, not recruiting
N/A
203
US
ReActiv8
Mainstay Medical
Chronic Low-back Pain
09/24
01/26
Co-Care, NCT06116266: Collaborative Care for Polysubstance Use in Primary Care Settings

Recruiting
N/A
350
US
Education and support for primary care providers (PCPS), Nurse Care Manager (NCM) visits, Addiction specialist consultant, Health coaching sessions, Patient educational materials
NYU Langone Health, National Institute on Drug Abuse (NIDA)
Substance Use
06/26
12/26

Download Options